New first-line treatment strategies for advanced lung squamous cell carcinoma

被引：0
|
作者：
Cai, Xiuyu [1 ,2 ,3 ]
Yu, Hui [1 ,2 ,3 ]
Cai, Yanyu [1 ,2 ,3 ]
Zhang, Bei [1 ,2 ,3 ]
Zhou, Yixin [1 ,2 ,3 ]
机构：
[1] State Key Lab Oncol South China, Guangzhou 510060, Peoples R China
[2] Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China
[3] Sun Yat Sen Univ, Dept VIP Reg, Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510060, Peoples R China
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2020年 / 9卷 / 02期
关键词：
CANCER; CHEMOTHERAPY;
D O I：
10.21037/tlcr.2020.03.14
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：414 / 417
页数：4
相关论文
共 50 条
  • [1] Nimotuzumab combined with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma
    Si, Xiaoyan
    Wu, Shafei
    Wang, Hanping
    Zhang, Xiaotong
    Wang, Mengzhao
    Zeng, Xuan
    Zhang, Li
    [J]. THORACIC CANCER, 2018, 9 (08) : 1056 - 1061
  • [2] New approaches to first-line treatment of advanced renal cell carcinoma
    George, Daniel J.
    Lee, Chung-Han
    Heng, Daniel
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [3] First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine
    Kourousis, C
    Androulakis, N
    Kakolyris, S
    Souglakos, J
    Maltezakis, G
    Metaxaris, G
    Chalkiadakis, G
    Samonis, G
    Vlachonikolis, J
    Georgoulias, V
    [J]. CANCER, 1998, 83 (10) : 2083 - 2090
  • [4] Immune checkpoint inhibitors for first-line treatment of advanced esophageal squamous cell carcinoma
    Alsina, Maria
    Fleitas-Kanonnikoff, Tania
    [J]. MED, 2024, 5 (09): : 1038 - 1040
  • [5] Necitumumab: a new option for first-line treatment of squamous cell lung cancer
    Jimenez Aguilar, Elizabeth
    Zugazagoitia Fraile, Jon
    Paz-Ares Rodriguez, Luis
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (08) : 765 - 772
  • [6] New First-Line Systemic Treatment Options for Metastatic Esophageal Squamous Cell Carcinoma
    Gibson, Michael K.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 579 - 582
  • [7] FIRST-LINE CHEMOTHERAPY WITH CARBOPLATIN AND DOCETAXEL FOR ADVANCED SQUAMOUS CELL LUNG CANCER
    Terashima, T.
    Matsuzaki, T.
    Fujiwara, H.
    Nakaya, A.
    Matsumoto, K.
    Ogawa, R.
    Naitou, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 134 - 134
  • [8] Selecting the right chemotherapy in first-line advanced squamous cell carcinoma of the anus
    Ducreux, M.
    Kim, S.
    Borg, C.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (03) : 349 - 350
  • [9] Phase II study of nedaplatin and amrubicin as first-line treatment for advanced squamous cell lung cancer
    Taniguchi, Hirokazu
    Yamaguchi, Hiroyuki
    Dotsu, Yosuke
    Shimada, Midori
    Gyotoku, Hiroshi
    Senju, Hiroaki
    Takemoto, Shinnosuke
    Kitazaki, Takeshi
    Fukuda, Masaaki
    Ogawara, Daiki
    Soda, Hiroshi
    Nakatomi, Katsumi
    Sugasaki, Nanae
    Kinoshita, Akitoshi
    Nagashima, Seiji
    Ikeda, Takaya
    Nakamura, Yoichi
    Sakamoto, Noriho
    Obase, Yasushi
    Fukuda, Minoru
    Mukae, Hiroshi
    [J]. THORACIC CANCER, 2019, 10 (09) : 1764 - 1769
  • [10] Cost-effectiveness analysis of serplulimab as first-line treatment for advanced esophageal squamous cell carcinoma
    Zheng, Zhiwei
    Fang, Ling
    Cai, Hongfu
    Zhu, Huide
    [J]. IMMUNOTHERAPY, 2023, 15 (13) : 1045 - 1055
12345